InvestorsHub Logo
Followers 55
Posts 6022
Boards Moderated 0
Alias Born 01/10/2004

Re: 2morrowsGains post# 1788

Friday, 03/26/2010 12:03:10 PM

Friday, March 26, 2010 12:03:10 PM

Post# of 18503
AEMD LOI with Membrana is subject to contractual agreement. I watched the latest CEO talk at RedChip conference. GREAT overview on the technology and therapies AEMD product can be used for. Very interesting stuff, particularly focus on Hep-C and commercialization in India. As CEO said, "AEMD does own the technology, but commercializing the technology will be tough".

IMHO, that contract with Membrana will make or break AEMD stock price, meaning AEMD doesn't have much cash in the bank, but their product has great potential for growth. Membrana has been making filters for a long time, and they are big enough to take AEMD pps to the floor or lift them to great new heights, depending on the tenacity of Membrana's contract negotiator and the direction they receive from Membrana's CEO.

The Form144 filings by 2 directors to sell 350,000 shares makes me think AEMD does not have enough leverage (cash on hand) to resist an aggressive negotiation by Membrana. In other words, Membrana knows that AEMD needs Membrana much more than vice versa.

AEMD has a great story; I'm just not sure they have the capacity (cash/size) to remain independent and grow use of their filtration systems to meet the need.

I'd love to know more about the technology (great benefits to patients worldwide) and growing use of the product.

'peeker

ps> Don't own AEMD yet, but looking for a good entry point, preferably under $.40/share.

MILKY WAY over Devil's Tower

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEMD News